Independent directory Public ClinicalTrials.gov records United States
Clear filters

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 16, 2026, 3:25 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 36 matching trials from the live ClinicalTrials.gov search.
Conditions
Carnitine Palmitoyl Transferase Type 1A (CPT1A) Deficiency
Interventions
Medically supervised fasting
Other
Lead sponsor
Oregon Health and Science University
Other
Eligibility
3 Years to 5 Years
Enrollment
12 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2007 – 2009
U.S. locations
1
States / cities
Portland, Oregon
Conditions
Diabetes
Interventions
MMT-7003 subcutaneous glucose sensor
Device
Lead sponsor
Medtronic MiniMed, Inc.
Industry
Eligibility
18 Years to 75 Years
Enrollment
63 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2009 – 2010
U.S. locations
3
States / cities
Escondido, California • Santa Barbara, California • Renton, Washington
Completed Not applicable Interventional Results available

CEP249 Pediatric Accuracy Study

NCT01991470
Conditions
Insulin Requiring Diabetes
Interventions
Enlite sensors
Device
Lead sponsor
Medtronic MiniMed, Inc.
Industry
Eligibility
2 Years to 18 Years
Enrollment
186 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2015 – 2016
U.S. locations
11
States / cities
Escondido, California • Torrance, California • Walnut Creek, California + 8 more
Conditions
Infant, Newborn, Hypoxia-Ischemia, Brain
Interventions
Induced hypothermia, Control
Device
Lead sponsor
NICHD Neonatal Research Network
Network
Eligibility
Up to 6 Hours
Enrollment
208 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
1999 – 2010
U.S. locations
16
States / cities
Birmingham, Alabama • Palo Alto, California • New Haven, Connecticut + 13 more
Conditions
Type 1 Diabetes
Interventions
Ultra-rapid insulin
Drug
Lead sponsor
Stanford University
Other
Eligibility
18 Years to 60 Years
Enrollment
16 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2023
U.S. locations
1
States / cities
Stanford, California
Conditions
Diabetes
Interventions
BD Continuous glucose monitor (BD CGM), YSI Glucose Analyzer, Medtronic Guardian CGM
Device
Lead sponsor
Becton, Dickinson and Company
Industry
Eligibility
18 Years to 65 Years
Enrollment
40 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2009
U.S. locations
1
States / cities
Chula Vista, California
Conditions
Diabetes
Interventions
Apollo Blood Glucose Monitoring System
Device
Lead sponsor
Ascensia Diabetes Care
Industry
Eligibility
18 Years to 75 Years
Enrollment
74 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2008 – 2009
U.S. locations
1
States / cities
Minneapolis, Minnesota
Completed Not applicable Interventional Accepts healthy volunteers Results available

User Performance of the Thunder Plus BGMS

NCT04008836
Conditions
Diabetes Mellitus
Interventions
T-PLUS Meter
Device
Lead sponsor
Ascensia Diabetes Care
Industry
Eligibility
18 Years and older
Enrollment
384 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2019
U.S. locations
1
States / cities
Walnut Creek, California
Completed Not applicable Interventional Accepts healthy volunteers Results available

Evaluation of Blood Glucose Meter Systems

NCT01714232
Conditions
Diabetes
Interventions
Contour® PLUS BGMS, OneTouch® SelectSimple™ BGMS, Accu-Chek® Performa BGMS, Accu-Chek® Active BGMS, Freestyle Freedom® BGMS
Device
Lead sponsor
Ascensia Diabetes Care
Industry
Eligibility
18 Years and older
Enrollment
106 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2012
U.S. locations
1
States / cities
Mishawaka, Indiana
Conditions
Diabetes
Interventions
Bayer G3 / Tatsu System, Accu-Chek® Aviva Nano Meter/Accu-Chek® Aviva Test Strips, Freestyle Lite® Meter and Test Strips with ZipwikTM tabs, OneTouch® Ultra®2 / OneTouch® Ultra® Blue Test Strips, One Touch® VerioTM Pro/One Touch® VerioTM Test Strips, Truetrack® Meter/Truetrack® Test Strips
Device
Lead sponsor
Ascensia Diabetes Care
Industry
Eligibility
18 Years and older
Enrollment
146 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2012
U.S. locations
1
States / cities
Renton, Washington
Completed No phase listed Interventional Results available

Performance of the L-PLUS BGMS by Persons With Diabetes Mellitus

NCT04033315
Conditions
Diabetes Mellitus
Interventions
L-PLUS meter
Device
Lead sponsor
Ascensia Diabetes Care
Industry
Eligibility
18 Years and older
Enrollment
130 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2019
U.S. locations
1
States / cities
Renton, Washington
Completed Not applicable Interventional Accepts healthy volunteers Results available

Protocol for the Evaluation of Dario™ BGMS Performance at Elevated Altitude

NCT02352298
Conditions
Diabetes
Interventions
Dario Blood Glucose Monitoring System, YSI Analyzer
Device
Lead sponsor
LabStyle Innovations Ltd.
Industry
Eligibility
18 Years and older
Enrollment
52 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2015
U.S. locations
1
States / cities
Aurora, Colorado
Completed Phase 1 Interventional

Pancreatic Clamp in NAFLD

NCT05724134
Conditions
Insulin Resistance, Prediabetic State, Hyperinsulinemia, Non-Alcoholic Fatty Liver Disease, Obesity
Interventions
Insulin human, Octreotide Acetate, Glucagon, Growth Hormone, Human, [6,6-2H2] D-glucose, 20% D-glucose (aq), BOOST Plus, CORE Bar, Harvard Apparatus PHD ULTRA CP syringe pump, Yellow Springs Instruments (YSI) 2500 Biochemistry Glucose/Lactate Analyzer
Drug · Other · Dietary Supplement + 1 more
Lead sponsor
Columbia University
Other
Eligibility
18 Years to 65 Years
Enrollment
18 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2023 – 2025
U.S. locations
1
States / cities
New York, New York
Conditions
Diabetes Mellitus
Interventions
non-invasive tissue glucose prediction
Device
Lead sponsor
Sciema UG
Other
Eligibility
18 Years to 90 Years
Enrollment
40 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2018 – 2019
U.S. locations
1
States / cities
San Mateo, California
Conditions
Diabetes Mellitus
Interventions
Freestyle Libre Flash Glucose Monitoring System
Device
Lead sponsor
Abbott Diabetes Care
Industry
Eligibility
18 Years and older
Enrollment
153 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2018
U.S. locations
5
States / cities
Escondido, California • Santa Barbara, California • Walnut Creek, California + 2 more
Conditions
Diabetes Mellitus
Interventions
Apollo Blood Glucose Monitoring System
Device
Lead sponsor
Ascensia Diabetes Care
Industry
Eligibility
18 Years to 75 Years
Enrollment
102 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2008
U.S. locations
1
States / cities
Fairfield, New Jersey
Conditions
Diabetes
Interventions
DIDGET (Investigational Blood Glucose Monitoring System)
Device
Lead sponsor
Ascensia Diabetes Care
Industry
Eligibility
4 Years to 24 Years
Enrollment
123 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2009
U.S. locations
2
States / cities
Escondido, California • Tallahassee, Florida
Completed Not applicable Interventional Results available

Biolinq Safety and Effectiveness Trial

NCT06229743
Conditions
Diabetes, Diabetes Mellitus
Interventions
Biolinq System
Device
Lead sponsor
Biolinq Inc.
Industry
Eligibility
22 Years and older
Enrollment
247 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2024
U.S. locations
6
States / cities
Escondido, California • Walnut Creek, California • Atlanta, Georgia + 3 more
Conditions
Diabetes Mellitus
Interventions
Non-invasive Optical Glucose Monitor™, YSI blood glucose analyzer
Device
Lead sponsor
C8 MediSensors, Inc.
Industry
Eligibility
18 Years and older
Enrollment
86 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2012 – 2013
U.S. locations
1
States / cities
San Jose, California
Conditions
Type1 Diabetes Mellitus, Type 2 Diabetes Mellitus
Interventions
LabPatch Continuous Glucose Monitoring (CGM)
Device
Lead sponsor
Joslin Diabetes Center
Other
Eligibility
18 Years to 75 Years
Enrollment
30 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2017 – 2019
U.S. locations
1
States / cities
Boston, Massachusetts
Conditions
Diabetes Mellitus
Interventions
blood glucose measurement
Other
Lead sponsor
Sciema UG
Other
Eligibility
18 Years and older
Enrollment
543 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2019
U.S. locations
1
States / cities
Renton, Washington
Conditions
Type 1 Diabetes
Interventions
Continuous Glucose Monitor (CGM)
Device
Lead sponsor
Nemours Children's Clinic
Other
Eligibility
12 Years to 18 Years
Enrollment
10 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2012 – 2014
U.S. locations
1
States / cities
Jacksonville, Florida
Conditions
Insulin Resistance, Prediabetic State, Non-Alcoholic Fatty Liver Disease, Overweight and Obesity
Interventions
Insulin human, Octreotide Acetate, Glucagon, Human Growth Hormone, Dexamethasone Oral, [6,6-2H2] D-glucose, 20% D-glucose (aq), BOOST Plus, Harvard Apparatus PHD ULTRA CP syringe pump, Yellow Springs Instruments (YSI) 2500 Biochemistry Glucose/Lactate Analyzer, Normal saline, Human albumin
Drug · Other · Dietary Supplement + 1 more
Lead sponsor
Columbia University
Other
Eligibility
18 Years to 65 Years
Healthy volunteers
Healthy volunteers not accepted
Timeline
2024 – 2026
U.S. locations
1
States / cities
New York, New York
Not listed Not applicable Interventional

MANAGE Automated Glucose Monitoring

NCT02211300
Conditions
ICU/CCU Patients Requiring Blood Glucose Monitoring
Interventions
The OptiScanner, YSI 2300 STAT Plus™
Device
Lead sponsor
OptiScan Biomedical Corporation
Industry
Eligibility
18 Years and older
Enrollment
230 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2014 – 2015
U.S. locations
4
States / cities
Boston, Massachusetts • St Louis, Missouri • Portland, Oregon + 1 more